However, rapamycin has evolved as an anti-aging drug currently explored for several indications in human clinical trials [50], and established immunomodulatory drugs (such as corticosteroids, azathioprine and monoclonal antibodies targeting TNF) may impact autophagy functions, collectively supporting the use of autophagy therapies in IBD [51]. Here, TNF is linked to inflammatory bowel disease.